COMPLEMENT-DEPENDENT CYTOLYTIC ANTI-TRICHOMONAS VAGINALIS MONOCLONAL ANTIBODY AND USE THEREOF IN THERAPY AND IN DIAGNOSIS

摘要

Novel monoclonal antibodies specific to Trichomonas vaginalis, having complement - fixing ability and lysing Trichomonas vaginalis in the presence of complement are disclosed and may be used in therapy and diagnosis of trichomoniasis. Hybridomas producing and compositions comprising these antibodies are also disclosed.